Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D K Cooper

Showing results (61-70 of 330) with videos related to

Pageof 33
Sort By:
Transplantation Proceedings|October 1, 1988
Triiodothyronine therapy in the cardiac transplant recipientD Novitzky, D K Cooper, N Zuhdi
The Journal of Heart Transplantation|November 1, 1986
Value of triiodothyronine (T3) therapy to brain-dead potential organ donorsD Novitzky, D K Cooper, B Reichart
Lancet (London, England)|September 11, 1993
Genetically engineered pigsD K Cooper, E Koren, R Oriol
Transplantation Proceedings|June 1, 1994
Clinical potential of xenotransplantationD K Cooper, E Koren, R Oriol
Transplantation Proceedings|April 1, 1996
Experimental discordant xenotransplantationD K Cooper, E Koren, R Oriol
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 1, 1991
Risk of endocarditis in donor heartsY Yokoyama, D K Cooper, N Zuhdi
Transplantation|May 1, 1992
Cytomegalovirus disease in heart transplant patientsA Jazzar, D K Cooper, N Zuhdi
Immunological Reviews|October 1, 1994
Oligosaccharides and discordant xenotransplantationD K Cooper, E Koren, R Oriol
Transplantation|June 1, 1987
Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donorsD Novitzky, D K Cooper, B Reichart
Clinical Transplantation|April 16, 1998
Hepatitis C status of heart transplant recipientsS Fagiuoli, D K Cooper, N Zuhdi
Pageof 33

Showing results (61-70 of 330) with videos related to

Sort By:
Pageof 33
Transplantation Proceedings|October 1, 1988
Triiodothyronine therapy in the cardiac transplant recipientD Novitzky, D K Cooper, N Zuhdi
The Journal of Heart Transplantation|November 1, 1986
Value of triiodothyronine (T3) therapy to brain-dead potential organ donorsD Novitzky, D K Cooper, B Reichart
Lancet (London, England)|September 11, 1993
Genetically engineered pigsD K Cooper, E Koren, R Oriol
Transplantation Proceedings|June 1, 1994
Clinical potential of xenotransplantationD K Cooper, E Koren, R Oriol
Transplantation Proceedings|April 1, 1996
Experimental discordant xenotransplantationD K Cooper, E Koren, R Oriol
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 1, 1991
Risk of endocarditis in donor heartsY Yokoyama, D K Cooper, N Zuhdi
Transplantation|May 1, 1992
Cytomegalovirus disease in heart transplant patientsA Jazzar, D K Cooper, N Zuhdi
Immunological Reviews|October 1, 1994
Oligosaccharides and discordant xenotransplantationD K Cooper, E Koren, R Oriol
Transplantation|June 1, 1987
Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donorsD Novitzky, D K Cooper, B Reichart
Clinical Transplantation|April 16, 1998
Hepatitis C status of heart transplant recipientsS Fagiuoli, D K Cooper, N Zuhdi
Pageof 33